Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Next and Synthomer cut outlook; new M&G CEO

Thu, 29th Sep 2022 07:49

(Alliance News) - The mood soured just before the European equities open on Thursday.

The Swedish Coast Guard found another leak in undersea gas pipelines running from Russia to Europe.

Stocks had initially been called higher on Thursday, with the Bank of England's bond market intervention lifting the mood.

The Nord Stream news put paid to hopes for a positive open in Europe, however.

"There are two leaks on the Swedish side and two leaks on the Danish side," a Swedish Coast Guard official said, after three leaks were confirmed earlier this week on the Nord Stream pipelines in the Baltic Sea.

Meanwhile, UK retailer Next lowered its guidance for annual sales and profit.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called down 0.3% at 6,982.29

----------

Hang Seng: down 0.8% at 17,105.61

Nikkei 225: closed up 1.0% at 26,422.05

S&P/ASX 200: closed up 1.4%. at 6,555.00

----------

DJIA: closed up 548.75 points, or 1.9%, at 29,683.74

S&P 500: closed up 71.75 points, or 2.0%, at 3,719.04

Nasdaq Composite: closed up 222.13 points, or 2.1%, at 11,051.64

----------

EUR: up at USD0.9660 (USD0.9645)

GBP: firm at USD1.0772 (USD1.0763)

USD: up at JPY144.68 (JPY144.41)

GOLD: lower at USD1,644.93 per ounce (USD1,653.20)

OIL (Brent): flat at USD88.23 a barrel (USD88.17)

(changes since previous London equities close)

----------

ECONOMICS

----------

Thursday's key economic events still to come:

1000 BST eurozone economic sentiment indicator

1300 BST Germany consumer price index

1330 BST US gross domestic product

1330 BST US initial jobless claims

----------

Kemi Badenoch has used her first overseas visit as UK trade secretary to defend the government's economic strategies as "going for growth in a big way". There has been controversy since Chancellor Kwasi Kwarteng last week announced his mini-budget, which included plans to cut taxes to the benefit of the most wealthy. Badenoch told investors at the fifth annual Atlantic Future Forum hosted on the HMS Queen Elizabeth, moored in New York, the strategies were necessary due to a "global growth slow-down". The former Tory leadership candidate outlined a number of the government's strategies to the forum, where UK businesses across the defence and technology sector aimed to attract US investors.

----------

The number of cars built in the UK has increased for the fourth month in a row, new figures show. A total of 49,901 cars were built in August, up 34% compared with a year ago, the Society of Motor Manufacturers & Traders said. But the figure was well below August 2019's pre-pandemic level of 92,158 units, which the SMMT said underlined the scale of recovery still needed in the industry. Production of battery electric, plug-in hybrid and hybrid vehicles increased. Almost a third of all cars made in Britain in August were one of these models, with most exported to global markets.

----------

Price sensitivity is showing signs of returning to the UK housing market as house hunters' buying power takes a hit, according to a property website. Zoopla said 6% of homes listed for sale have seen the asking price adjusted downwards by 5% or more, marking the highest level since before the coronavirus pandemic. The website said that, given the economic backdrop and factors including rising energy prices and rising interest rates, this is a clear sign of a return to more of a buyers' market, after two years of a market that favoured sellers. The findings were released in a week when a slew of mortgage products have been pulled from the market and rates have been hiked, amid turmoil after the mini-budget last Friday.

----------

BROKER RATING CHANGES

----------

Oddo BHF raises GSK to 'outperform' ('neutral') - price target 1,700 (1,540) pence

----------

RBC cuts THG to 'sector perform' ('outperform') - price target 50 (215) pence

----------

RBC cuts boohoo price target to 35 (65) pence - 'sector perform'

----------

Goldman Sachs cuts boohoo price target to 65 (115) pence - 'buy'

----------

COMPANIES - FTSE 100

----------

Next lowered annual guidance as the clothing and homewares retailer believes tough trading in August and cost-of-living pressures will offset any boost from recent UK government stimulus measures. In the half-year ended July 30, revenue climbed 12% to GBP2.38 billion from GBP2.12 billion a year earlier. Pretax profit advanced 16% year-on-year to GBP400.6 million from GBP346.7 million. Full price sales advanced 12% year-on-year in the first half, though the company now expects a decline for the second half. Full price sales are to shrink by 1.5% year-on-year. It had previously guided for 1% growth. Next also lowered bottom-line guidance. It now expects annual pretax profit of GBP840 million, down from the previous GBP860 million guidance, but up 2.1% on last year. "August trade was below our expectations and cost of living pressures are set to rise in the coming months. Sales in September have improved, and we may see benefits from recent government measures," Next said, adding that the decision to lower full price sales guidance was a "very difficult call". Next, returning to a normal dividend cycle, declared a 66 pence per share interim payout. It expects to declare a final dividend "no lower than" the 127p it paid in August.

----------

Holiday Inn-owner InterContinental Hotels said it is carrying out extra "recovery and assurance plans" after its technology systems were hit by "unauthorised activity" earlier this month. "Following a period of disruption, by Wednesday 7 September IHG had re-activated its booking websites and mobile app together with most of its other booking channels and revenue-generating systems. Subsequently, service at our reservation and customer care call centres has been recovered and all our systems restored," the company explained. During the disruption, its hotel sites were able to to take booking directly. "We have continued to carry out additional steps as part of our recovery and assurance plans to review and further enhance our security measures. External specialists were engaged to investigate the incident, and no evidence of unauthorised access to systems storing guest data has been identified," IHG added.

----------

M&G has named Andrea Rossi as its new chief executive, effective October 10. He succeeds John Foley who steps down after seven years in the post. Foley's retirement from the role was announced in April. The wealth manager at the time said Foley would remain in the role until a replacement was found. Rossi was formerly CEO of AXA Investment Managers and spent six years on the executive committee of parent AXA SA. "Most recently, Andrea has been a senior adviser to Boston Consulting Group. He will step down from this role following his appointment at M&G," M&G added.

----------

COMPANIES - FTSE 250

----------

Mitchells & Butlers said fourth-quarter sales topped pre-virus levels, despite the pub and bar owner facing extreme hot weather in the UK and rail strikes. In the quarter ended September 24, total sales rose 1.5% from three years earlier, before the onset of the pandemic. "Like-for-like sales improved in the fourth quarter, despite the ongoing impact of extreme heat as well as further rail strikes, both of which disrupted trade. Sales over the August bank holiday were encouraging, with like-for-like growth over the three-day weekend of over 6%, before returning to levels consistent with the quarter as a whole," the company said. For the full-year, sales were up 1.1% on pre-virus levels. Mitchells & Butlers welcome UK energy price cap measures but warned it expects its total energy and utility costs to have risen to GBP150 million for the full year, up from the pre-pandemic comparative of GBP80 million. "Even with the cap in place anticipate a further increase on that for FY 2023," it warned.

----------

Synthomer cut yearly guidance as the Essex-based chemicals maker grapples with tough market conditions. It now expects its 2022 earnings before interest, tax, depreciation and amortisation to be 10% to 15% below previous expectations. "Since August, macroeconomic conditions have deteriorated, leading to reduced demand in construction and coatings end markets. This has impacted trading in Synthomer's European business," the company warned.

----------

OTHER COMPANIES

----------

Attraqt backed a GBP63.2 million takeover offer. Technology company Crownpeak will pay 30p per share in the London-based provider of online search, merchandising and personalisation solutions for e-commerce. This represents a 70% premium to Attraqt's 17.50p closing price on Wednesday. The bid values Attraqt's equity at GBP63.2 million. Crownpeak has so far received acceptances representing 42% of Attraqt shareholders. Attraqt also reported interim results. In the first half of 2022, revenue climbed 9.4% annually to GBP12.2 million from GBP11.1 million. Its pretax loss, however, widened to GBP2.2 million from GBP1.8 million.

----------

Avon Protection said it has received a first delivery order from the US Army for a "next generation" helmet. The order is worth USD42.1 million. "Manufacturing ramp-up is progressing to plan after completing rigorous testing, with initial deliveries commencing in the first half of FY23 positioning Avon Protection as the leading helmet supplier to the US [Department of Defense]," the company said.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.